与酒精有关的发作患者的发作复发和发作的临床特征
Min Young Chun1,2,3, Hyungmi An4, Hye Ah Lee5
1Department of Neurology, Ewha Womans University Mokdong Hospital, Seoul, South Korea.
Alcohol, clinical & experimental research
|September 27, 2024
概括
高度饮酒会导致经常性发作和. 早期识别风险因素对于干预和管理与酒精有关的发作至关重要,可能预防发作的发展.
科学领域:
- 神经学 神经学
- 成 药物 药物 药物 药物
- 临床神经科学 临床神经科学
背景情况:
- 戒酒发作在慢性酒精使用者中很常见.
- 慢性酒精使用可能导致,需要抗药物 (AED) 治疗.
- 了解发作复发和发作的预测因素至关重要.
研究的目的:
- 为了研究与酒精有关的发作的临床特征.
- 为了确定发作复发和发作的预后因素.
- 评估这些结果的预测模型的性能.
主要方法:
- 对191名患有与酒精有关的发作的患者进行了回顾性分析.
- 收集的数据包括酒精戒断的持续时间,发作类型,并发症和临床特征.
- 使用后勤回归和接收器运行特征 (ROC) 曲线分析来识别风险因素并评估模型性能.
主要成果:
- 51.8%的患者经历了发作的复发,41.4%患上了.
- 预测复发的因素包括酒精消费水平,焦点受损意识发作,焦虑和头痛.
- 预测模型表现出强的性能 (复发时AUC为0.833,时AUC为0.939).
结论:
- 高度的酒精消费和特定的临床/诊断特征预测了发作复发和.
- 早期识别和干预对于预防发作复发和发作至关重要.
- 抗药物 (AED) 治疗对于管理这些疾病很重要.
相关概念视频
Seizures: Classification
307
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
307
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
Antiepileptic Drugs: Glutamate Antagonists
292
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
292
Antiepileptic Drugs: GABAergic Pathway Potentiators
341
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341
Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149


